3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
4
Vascular Neoplasms
1
Solitary Fibrous Tumors
1
Smooth Muscle Tumor
1
Sarcoma, Clear Cell
1
Sarcoma
1
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Osteosarcoma
1
Neurofibrosarcoma
1
Nerve Sheath Neoplasms
1
Neoplasms, Adipose Tissue
1
Myoepithelioma
1
Myeloproliferative Disorders
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Liposarcoma, Myxoid
1
Liposarcoma
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Hodgkin Disease
1
Histiocytoma, Angiomatoid Fibrous
1
Hemangiosarcoma
1
Hemangioendothelioma, Epithelioid
1
Granuloma, Plasma Cell
1
Granular Cell Tumor
1
Glomus Tumor
1
Glioma
1
Glioblastoma
1
Fibrosarcoma
1
Interventions
fludarabine
9
Cyclophosphamide
8
fludarabine phosphate
7
Specimen Handling
7
Cytarabine
7
Biopsy
7
venetoclax
6
Whole-Body Irradiation
6
Busulfan
6
Azacitidine
6
Mycophenolic Acid
5
Melphalan
5
Injections
5
decitabine and cedazuridine drug combination
4
Tacrolimus
4
Granulocyte Colony-Stimulating Factor
4
Filgrastim
4
Cyclosporine
4
CPX-351
4
X-Rays
3
Stem Cell Transplantation
3
Peripheral Blood Stem Cell Transplantation
3
Magnetic Resonance Spectroscopy
3
treosulfan
2
ruxolitinib
2
luspatercept
2
ivosidenib
2
gilteritinib
2
Sirolimus
2
Photons
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
selinexor
×
30 days
×
Clear all
No trials found.